Rat Models of Retinal Ganglion Cell Degeneration in the MICRON Literature

About the MICRON Research Literature

These research pages organize published studies using MICRON imaging systems by animal species and the disease or condition investigated.

All publication counts and figures reflect the complete indexed research collection.

Explore related studies through the MICRON Research Hubs or search the complete publication collection in the reSEARCH portal.

Understanding Retinal Ganglion Cell Degeneration

Retinal ganglion cells are the output neurons of the retina, gathering the processed visual signal from the inner retina and carrying it to the brain along the axons that make up the optic nerve.

Their degeneration is a cellular outcome rather than a disease in its own right: it is a common endpoint of conditions with quite different causes, so what drove the loss in a given study has to be read from that study and not from the fact of the loss.

It matters because the loss is not made good on its own:

• Ganglion cells that die are not spontaneously replaced
• In adult mammals their axons do not spontaneously regrow along the optic nerve

Vision lost by this route does not return of itself. Whether it can be restored by intervention is a separate question, and one settled by what a given study did rather than by the fact of the loss.

Retinal Ganglion Cell Degeneration in Experimental Research

An animal model of ganglion-cell degeneration supplies that population in a form that can be counted and followed directly. What can be counted and followed includes:

• Somata countable in flat-mounted retina and axons in optic-nerve cross-section
• Inner-retinal structure and ganglion-cell-driven function measurable over time

Where the preparation is genetic or experimentally induced, the initiating cause is also known from construction. In a spontaneous model, onset and mechanism have to be established from the model itself rather than assumed from the endpoint.

What such a model does not supply is the human clinical endpoint:

• A visual field defect is a psychophysical measurement that needs a subject who can respond
• Macular ganglion cell complex thinning, used to quantify the loss in people, has no macular counterpart in a mouse or rat retina, since neither species has a macula and the equivalent structural measurement there is of the inner retina as a whole

The time base differs as well, since rodent models of ganglion cell loss run their course in weeks to months while human conditions ending in ganglion cell loss can develop over years.

Rat Models of Retinal Ganglion Cell Degeneration

The rat offers a larger eye than the mouse while remaining a small-animal model, which eases injection and imaging without moving to a large species.

Published MICRON Research: Retinal Ganglion Cell Degeneration in Rats

This page lists 24 papers from the MICRON literature, published 2012 to 2026, that study retinal ganglion cell degeneration in rats.

Of these publications:

• 24 studies used rats as the primary retinal ganglion cell degeneration disease model.

Scope of the literature collection: Publication counts reflect studies identified and indexed in the MICRON research corpus. This collection is not intended to represent an exhaustive review of all published retinal ganglion cell degeneration research.

Which imaging and experimental techniques are used in these studies?

Technique counts are paper-level co-occurrences and do not necessarily indicate that a technique was applied to the focal species or focal disease model.

Capabilities and Limitations of Imaging Techniques

A summary of what each imaging technique listed above can measure, the information it provides, and its limitations in research applications.

Optical Coherence Tomography

Optical coherence tomography provides high-resolution, cross-sectional images of ocular tissues in the living eye, allowing researchers to visualize structures at different depths. OCT is particularly useful for measuring tissue thickness, identifying structural abnormalities, and assessing the location and extent of tissue changes.

As a non-invasive imaging technique, OCT enables repeated measurements in the same eye over time, supporting longitudinal studies of disease progression and treatment response. Although OCT provides detailed structural information, it does not directly measure cellular activity or visual function. Tissue that appears structurally normal may still have functional abnormalities, making OCT a valuable companion to functional assessments such as electroretinography (ERG).

Intravitreal Injection / Delivery

Injection into the vitreous places a substance directly into the vitreous at a known administered dose and chosen time, reducing but not eliminating systemic exposure. The injectate may be a therapeutic compound, cell preparation or viral vector, or an agent used to create the model, such as a toxin, vasoactive or excitotoxic compound, or infectious inoculum. The route bypasses surface-delivery barriers and provides direct access to the vitreous and posterior segment, but the concentration reached in a particular ocular tissue depends on distribution and clearance and is not fixed by the injected dose alone. It is invasive and discrete: each repeat dose or challenge requires another injection, and vehicle- or sham-injected controls can help separate effects of the injectate from effects of the procedure.

Electroretinography

Records the retina's electrical response to light, giving component-sensitive information about outer- and inner-retinal function. It measures function directly, which no structural method does. Full-field ERG sums across the whole retina, so a small lesion can leave the trace unchanged; focal and multifocal variants trade signal amplitude for spatial resolution.

Topical Ophthalmic Drug Delivery

A compound applied as drops to the ocular surface. It is non-invasive and repeatable, so it supports frequent dosing without a procedure for each dose. What the route has to establish depends on the target: for an ocular-surface target, residence time and penetration into the surface tissue are the main barriers; for an intraocular anterior-segment target, the compound must cross ocular-surface and corneal or conjunctival barriers and reach an intraocular concentration sufficient for the experiment; for a posterior-segment target, additional ocular barriers separate the surface from the target and posterior-segment exposure is harder to establish.

Optokinetic / Optomotor Response

Measures a reflexive head or eye movement tracking a moving pattern, giving a rapid, training-free behavioral estimate of spatial vision and contrast sensitivity in an animal that cannot report them. It is driven largely by reflex circuitry and reports on the visual pathway as a whole, so a deficit it detects still has to be localized by a structural or electrophysiological method, or separated from cortical processing by an operant task.

Which MICRON systems and add-ons appear?

Which strains and genetic lines are used?

Which other species appear alongside?

What other conditions are recorded on the same papers?

Which MICRON configurations appear in this work?

Configurations recorded in these papers, and the techniques recorded alongside them.

The papers

Browse all hubs at MICRON Research Hubs. The full corpus is searchable in the reSEARCH portal.